The Westlake Village, California-based biotech is developing treatments for brain cancers like glioma and meningioma ... the chemotherapeutic drug temozolomide with POH. The company is currently ...

Patient was not treated with temozolomide as MGMT promoter methylation in the ... choroid plexus tumours, meningiomas or nerve sheath tumours in the setting of neurofibromatosis, atypical ...

Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells.

Participants found to have a methylated MGMT status from their surgery will also receive temozolomide. Participants in the Standard of Care Group will receive standard-of-care radiation plus ...